Bio-oriented synthesis of new sulphadiazine derivatives for urease inhibition and their pharmacokinetic analysis

Abstract Current research is based on biology-oriented synthesis of sulphadiazine derivatives and determination of their urease inhibitory activity. In this regard, a series of (E)-4-(benzylideneamino)-N-(pyrimidin-2-yl)benzenesulfonamide was synthesized from sulphadiazine and substituted aromatic a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Asad Hamad, Mohsin Abbas Khan, Irshad Ahmad, Ruqaiya Khalil, Muhammad Khalid, Urva Abbas, Rahat Azhar, Jalal Uddin, Gaber El-Saber Batiha, Ajmal Khan, Zahid Shafiq, Ahmed Al-Harrasi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b3f54ea4bfa3458e9557fb8910cb5571
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b3f54ea4bfa3458e9557fb8910cb5571
record_format dspace
spelling oai:doaj.org-article:b3f54ea4bfa3458e9557fb8910cb55712021-12-02T18:48:02ZBio-oriented synthesis of new sulphadiazine derivatives for urease inhibition and their pharmacokinetic analysis10.1038/s41598-021-98413-x2045-2322https://doaj.org/article/b3f54ea4bfa3458e9557fb8910cb55712021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98413-xhttps://doaj.org/toc/2045-2322Abstract Current research is based on biology-oriented synthesis of sulphadiazine derivatives and determination of their urease inhibitory activity. In this regard, a series of (E)-4-(benzylideneamino)-N-(pyrimidin-2-yl)benzenesulfonamide was synthesized from sulphadiazine and substituted aromatic aldehydes. The structures of synthesized compounds were ascertained by spectroscopic techniques, such as, FTIR, NMR and HRMS analysis, and in-vitro and in-silico investigation were carried out for the inhibition of urease. Ureases are harmful for humans by producing by-products of urea (ammonia and carbon dioxide). The most active compound (3l) against urease exhibited IC50 value of 2.21 ± 0.45 µM which is 10 times more potent than the standard thiourea (20.03 ± 2.06 µM). It is noteworthy that most of our synthesized compounds showed significant to excellent activities against urease enzyme and most of them substituted by halogen or hydroxy groups at ortho and para positions in their structures. Inhibition of enzyme by the synthesized analogues was in descending order as 3l > 3a > 3b > 3q > 3e > 3o > 3s > 3t > 3g > 3k > 3r > 3f > 3m > 3p > 3n > 3j > 3i > 3h. Moreover, molecular docking studies were performed to rationalize the binding interactions of the synthesized motifs with the active pocket of the urease enzyme. The synthesized sulphadiazine derivatives (3a–u) were found to be non-toxic, and presented passive gastrointestinal absorption.Asad HamadMohsin Abbas KhanIrshad AhmadRuqaiya KhalilMuhammad KhalidUrva AbbasRahat AzharJalal UddinGaber El-Saber BatihaAjmal KhanZahid ShafiqAhmed Al-HarrasiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Asad Hamad
Mohsin Abbas Khan
Irshad Ahmad
Ruqaiya Khalil
Muhammad Khalid
Urva Abbas
Rahat Azhar
Jalal Uddin
Gaber El-Saber Batiha
Ajmal Khan
Zahid Shafiq
Ahmed Al-Harrasi
Bio-oriented synthesis of new sulphadiazine derivatives for urease inhibition and their pharmacokinetic analysis
description Abstract Current research is based on biology-oriented synthesis of sulphadiazine derivatives and determination of their urease inhibitory activity. In this regard, a series of (E)-4-(benzylideneamino)-N-(pyrimidin-2-yl)benzenesulfonamide was synthesized from sulphadiazine and substituted aromatic aldehydes. The structures of synthesized compounds were ascertained by spectroscopic techniques, such as, FTIR, NMR and HRMS analysis, and in-vitro and in-silico investigation were carried out for the inhibition of urease. Ureases are harmful for humans by producing by-products of urea (ammonia and carbon dioxide). The most active compound (3l) against urease exhibited IC50 value of 2.21 ± 0.45 µM which is 10 times more potent than the standard thiourea (20.03 ± 2.06 µM). It is noteworthy that most of our synthesized compounds showed significant to excellent activities against urease enzyme and most of them substituted by halogen or hydroxy groups at ortho and para positions in their structures. Inhibition of enzyme by the synthesized analogues was in descending order as 3l > 3a > 3b > 3q > 3e > 3o > 3s > 3t > 3g > 3k > 3r > 3f > 3m > 3p > 3n > 3j > 3i > 3h. Moreover, molecular docking studies were performed to rationalize the binding interactions of the synthesized motifs with the active pocket of the urease enzyme. The synthesized sulphadiazine derivatives (3a–u) were found to be non-toxic, and presented passive gastrointestinal absorption.
format article
author Asad Hamad
Mohsin Abbas Khan
Irshad Ahmad
Ruqaiya Khalil
Muhammad Khalid
Urva Abbas
Rahat Azhar
Jalal Uddin
Gaber El-Saber Batiha
Ajmal Khan
Zahid Shafiq
Ahmed Al-Harrasi
author_facet Asad Hamad
Mohsin Abbas Khan
Irshad Ahmad
Ruqaiya Khalil
Muhammad Khalid
Urva Abbas
Rahat Azhar
Jalal Uddin
Gaber El-Saber Batiha
Ajmal Khan
Zahid Shafiq
Ahmed Al-Harrasi
author_sort Asad Hamad
title Bio-oriented synthesis of new sulphadiazine derivatives for urease inhibition and their pharmacokinetic analysis
title_short Bio-oriented synthesis of new sulphadiazine derivatives for urease inhibition and their pharmacokinetic analysis
title_full Bio-oriented synthesis of new sulphadiazine derivatives for urease inhibition and their pharmacokinetic analysis
title_fullStr Bio-oriented synthesis of new sulphadiazine derivatives for urease inhibition and their pharmacokinetic analysis
title_full_unstemmed Bio-oriented synthesis of new sulphadiazine derivatives for urease inhibition and their pharmacokinetic analysis
title_sort bio-oriented synthesis of new sulphadiazine derivatives for urease inhibition and their pharmacokinetic analysis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/b3f54ea4bfa3458e9557fb8910cb5571
work_keys_str_mv AT asadhamad bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT mohsinabbaskhan bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT irshadahmad bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT ruqaiyakhalil bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT muhammadkhalid bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT urvaabbas bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT rahatazhar bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT jalaluddin bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT gaberelsaberbatiha bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT ajmalkhan bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT zahidshafiq bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
AT ahmedalharrasi bioorientedsynthesisofnewsulphadiazinederivativesforureaseinhibitionandtheirpharmacokineticanalysis
_version_ 1718377644825772032